Market closed

UCB/€UCB

08:00

10:10

12:15

14:25

16:30

1D1W1MYTD1Y5YMAX

About UCB

UCB SA, founded in 1928, is a global biopharmaceutical company headquartered in Brussels, Belgium. The company specializes in the research, development, and commercialization of innovative therapies primarily for the treatment of neurological and immunological disorders. Operating in the healthcare sector, UCB is dedicated to advancing science and addressing unmet medical needs for patients worldwide.

Ticker

€UCB

Sector

Health Care

Trading on

BSE

Industry

Pharmaceuticals

Headquarters

Brussels, Belgium

Employees

9,000

Website

www.ucb.com

UCB Metrics

BasicAdvanced

€36B

157.26 €1.22

0.35 €0.95

0.50%

Price and volume

Market cap

€36B

Beta

0.35

52-week high

€198.95

52-week low

€81.70

Average daily volume

171K

Dividend rate

€0.95

Financial strength

Current ratio

1.187

Quick ratio

0.66

Long term debt to equity

33.33

Total debt to equity

33.933

Dividend payout ratio (TTM)

107.92%

Interest coverage (TTM)

3.09%

Management effectiveness

Return on assets (TTM)

1.98%

Return on equity (TTM)

2.67%

Valuation

Price to earnings (TTM)

157.264

Price to revenue (TTM)

6.694

Price to book

4.05

Price to tangible book (TTM)

-64.91

Price to free cash flow (TTM)

64.165

Dividend yield (TTM)

0.50%

Forward dividend yield

0.50%

Growth

Revenue change (TTM)

6.71%

Earnings per share change (TTM)

-27.64%

3-year revenue growth (CAGR)

-0.38%

3-year earnings per share growth (CAGR)

-36.85%

3-year dividend per share growth (CAGR)

2.31%

What the Analysts think about UCB

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for UCB stock.

UCB Financial Performance

Income Statement

Revenues and expenses

QuarterlyAnnual

Q3 24

QoQ growth

Revenue

$37B

-39.75%

Net income

$45B

107.52%

Profit margin

37.65%

6.78%

UCB Earnings Performance

Earnings per share (EPS)

Company profitability

QuarterlyAnnual

Q4 23

Q1 24

Q2 24

Q3 24

Q4 24

Actual

$3.69

$2.85

$2.45

$2.42

-

Expected

$3.55

$2.61

$2.05

$2.31

$3.94

Surprise

3.94%

9.20%

19.51%

4.63%

-

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.

Market data provided by CBOE Europe

Buy €UCB

€

Capital at risk

Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for UCB stock?

UCB (UCB) has a market cap of €36B as of January 15, 2025.

What is the P/E ratio for UCB stock?

The price to earnings (P/E) ratio for UCB (UCB) stock is 157.26 as of January 15, 2025.

Does UCB stock pay dividends?

Yes, the UCB (UCB) stock pays dividends to shareholders. As of January 15, 2025, the dividend rate is €0.952 and the yield is 0.5%. UCB has a payout ratio of 107.92% on a trailing twelve-month basis.

When is the next UCB dividend payment date?

The next UCB (UCB) dividend payment date is unconfirmed.

What is the beta indicator for UCB?

UCB (UCB) has a beta rating of 0.35. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.